Free shipping on all orders over $ 500

C75

Cat. No. M2604

All AbMole products are for research use only, cannot be used for human consumption.

C75 Structure
Size Price Availability Quantity
5mg USD 120  USD120 In stock
10mg USD 190  USD190 In stock
25mg USD 380  USD380 In stock
50mg USD 600  USD600 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

C75 is a novel, potent synthetic inhibitor of fatty acid synthase (FAS), which is used as a tool for studying fatty acid synthesis in metabolic disorders and cancer. C75 inhibits FAS activity and stimulates carnitine palmitoyltransferase-1 (CPT-1) in primary cortical neurons, consistent with its effects in peripheral tissues. C75 alters neuronal ATP levels and AMP-activated protein kinase (AMPK) activity. C75 displays anorectic effects. C75 induces apoptosis in MCF-7 xenografts and exhibits anti-tumor activity. Several downstream pathways are affected by C75 treatment, including glucose metabolism and acetyl-CoA carboxylase (ACC) phosphorylation. C75 modulates the levels of energy intermediates, thus, affecting the energy sensor AMPK.

Chemical Information
Molecular Weight 254.32
Formula C14H22O4
CAS Number 218137-86-1
Solubility (25°C) DMSO 55 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Young-Chan Kim, et al. Nat Chem Biol. Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation

[2] Landree LE, et al. J Biol Chem. C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism.

[3] Zhou W, et al. Cancer Res. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.

Related FAS Products
Fasnall 

Fasnall is a selective fatty acid synthase (FASN) inhibitor with an IC50 of 3.71 μM.

Fasnall benzenesulfonate 

Fasnall benzenesulfonate is the benzenesulfonate salt form of Fasnall.

GSK837149A 

GSK837149A is a selective inhibitor of human Fatty Acid Synthase (FASN) targeting the KR domain. GSK837149A has reversible inhibition effect on FASN and selectivity for type I FASN (Ki=30 nM). GSK837149A is also a competitive inhibitor of NADPH and a non-competitive inhibitor of acetoacetyl-CoA. GSK837149A can be used for the research of obesity and breast cancer.

IPI-9119

IPI-9119 is an orally active, selective and irreversible Fatty Acid Synthase (FASN) inhibitor, with an IC50 of 0.3 nM.

Eicosapentaenoic acid ethyl ester

Eicosapentaenoic acid ethyl ester (AMR101, EPA ethyl ester, Ethyl eicosapentaenoate) is an omega-3 fatty acid agent that significantly reduces the triglyceride (TG) levels and improves other lipid parameters without significantly increasing the low-density lipoprotein (LDL) cholesterol levels.

  Catalog
Abmole Inhibitor Catalog




Keywords: C75 supplier, FAS, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.